Author:
Li Jingyao,Huang Aihong,Han Zhaojie,Zhou Yi,Tang Meng,Wu Wei,Zhang Shixin,Liao Kelong,Xie Yihui,Chen Qiao,Zou Xinliang,Liu Shuai,Gao Shuaixiang,Ren Junlong,Xu Qingyuan,Liu Xi,Liao Yi,Jing Tao,Tan WenFeng,Qiu Yang,Wang Haidong
Abstract
Abstract
Background
Postoperative lung cancer patients belong to the high-risk group for venous thromboembolism (VTE). The standardized preventive measures for perioperative VTE in lung cancer are not perfect, especially for the prevention and treatment of catheter-related thrombosis (CRT) caused by carried central venous catheters (CVCs) in lung cancer surgery.
Patients and methods
This study included 460 patients with lung cancer undergoing video-assisted thoracic surgery (VATS) in our center from July 2020 to June 2021. Patients were randomized into two groups, and intraoperatively-placed CVCs would be carried to discharge. During hospitalization, the control group was treated with low-molecular-weight heparin (LMWH), and the experimental group with LMWH + intermittent pneumatic compression (IPC). Vascular ultrasound was performed at three time points which included before surgery, before discharge, and one month after discharge. The incidence of VTE between the two groups was studied by the Log-binomial regression model.
Results
CRT occurred in 71.7% of the experimental group and 79.7% of the control group. The multivariate regression showed that the risk of developing CRT in the experimental group was lower than in the control group (Adjusted RR = 0.889 [95%CI0.799–0.989], p = 0.031), with no heterogeneity in subgroups (P for Interaction > 0.05). Moreover, the fibrinogen of patients in the experimental group was lower than control group at follow-up (P = 0.019).
Conclusion
IPC reduced the incidence of CRT during hospitalization in lung cancer patients after surgery.
Trial registration
No. ChiCTR2000034511.
Publisher
Springer Science and Business Media LLC